Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluproquazone for osteoarthritis

E C Huskisson, R Bryans, J Scott

    Rheumatology and Rehabilitation
    |May 1, 1981
    PubMed
    Summary

    Fluproquazone and indomethacin effectively reduced symptoms compared to placebo. While both drugs showed similar efficacy, more patients preferred indomethacin, with few side effects reported for either treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Four new anti-inflammatory drugs responses and variations.

    The Medical journal of Malaysia·2022
    Same author

    Catecholamine excretion and pain.

    British journal of clinical pharmacology·2012
    Same author

    Indomethacin or amylobarbitone sodium for sleep in rheumatoid arthritis, with some observations on the use of sequential analysis.

    British journal of clinical pharmacology·2012
    Same author

    Modern management of mild-to-moderate joint pain due to osteoarthritis: a holistic approach.

    The Journal of international medical research·2010
    Same author

    Glucosamine and chondroitin for osteoarthritis.

    The Journal of international medical research·2008
    Same author

    Nimesulide, a balanced drug for the treatment of osteoarthritis.

    Clinical and experimental rheumatology·2001

    Area of Science:

    • Pharmacology
    • Clinical Trials
    • Drug Efficacy

    Background:

    • Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for symptom management.
    • Evaluating novel NSAIDs against established treatments is crucial for therapeutic advancement.

    Purpose of the Study:

    • To compare the efficacy and patient preference of fluproquazone against indomethacin and placebo.
    • To assess the safety profile of fluproquazone in a clinical setting.

    Main Methods:

    • A double-blind, cross-over trial design was employed.
    • Participants received fluproquazone (100 mg t.d.s.), indomethacin (25 mg t.d.s.), and placebo.
    • Efficacy measures and patient preference were recorded.

    Main Results:

    • Both fluproquazone and indomethacin demonstrated superior efficacy compared to placebo.
    • The active treatments were comparable across most efficacy endpoints.
    • A statistically significant greater number of patients preferred indomethacin over fluproquazone.

    Conclusions:

    • Fluproquazone is an effective anti-inflammatory agent comparable to indomethacin.
    • Indomethacin may offer a better patient preference profile.
    • Both drugs exhibit a favorable safety profile with minimal adverse events.

    Related Experiment Videos